Abstract
• A replication-competent recombinant VSV with RABV-G protein replacement was generated. • Single dose of VSV-RABV(G) immunization induces potent anti-RABV(G) immune response, including viral neutralizing antibodies. • Mice intranasally immunized with single dose of VSV-RABV(G) were 100% protected upon RABV challenge.